MedPath
FDA Approval

Corphedra

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 17, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ephedrine(500 mg in 10 mL)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Corphedra

Product Details

NDC Product Code
42023-233
Application Number
NDA208943
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
August 14, 2021
EphedrineActive
Code: U6X61U5ZEGClass: ACTIBQuantity: 500 mg in 10 mL

Corphedra

Product Details

NDC Product Code
42023-196
Application Number
NDA208943
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
August 14, 2021
EphedrineActive
Code: U6X61U5ZEGClass: ACTIBQuantity: 50 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath